The expression of Beclin-1 and LC3II/I after 12 h, 24 h, and 48 h of CFS treatment was higher than that in the control group (Fig. 4). This evidence concerns the gene BECN1 and myalgic encephalomeyelitis/chronic fatigue syndrome.